Comments

Harmony Biosciences

Q: What sector and industry does Harmony Biosciences (HRMY) operate in?

Harmony Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

HRMYNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$35.84

0.952.72%

Pre-Market: 6:56 PM EDT

Q4 2024 Earnings in 4 days from now on Tue Feb 25th, before the market open

Conference call scheduled in 4 days at 8:30 AM Click to view the webcast

Harmony Biosciences (HRMY) Forecast

News Earnings Harmony Biosciences (HRMY) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Want to View Edge Rankings?

Unlock The Hidden Results With Your Benzinga Account Now.

Get Started

Harmony Biosciences (NASDAQ:HRMY) Stock Quotes, Forecast and News Summary

Harmony Biosciences Stock (NASDAQ: HRMY) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	23.00 / 548.89K
Day Range	- - -
52 Wk Range	28.14 - 41.61
Market Cap	$2.04B
P/E Ratio	16.54
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	29.14%
Days to Cover	5.95

Recent News

Harmony Biosciences Stock Falls On FDA Setback For Pitolisant In Sleeping Disorder

Harmony Biosciences' FDA setback for pitolisant in idiopathic hypersomnia doesn't impact its 2025 revenue outlook, with a Phase 3 trial planned for late 2025.

Vandana Singh

Why Harmony Biosciences (HRMY) Stock Is Down 18% Today

Harmony Biosciences shares are trading lower by 17% Wednesday afternoon. The company announced a public offering of up to 8 million common stock shares from selling shareholders.

Henry Khederian

Neurology-Focused Harmony Biosciences Gains Confidence With Wakix Sales Surge, Strategic Pipeline Expansion, Bullish Analyst Says

UBS has initiated coverage on Harmony Biosciences with a Buy rating and a price target of $56. UBS highlights Harmony's potential for growth, projecting a 19% CAGR for Wakix sales through 2026.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep 24

Oct 24

Dec 24

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	23.00 / 548.89K
Day Range	- - -
52 Wk Range	28.14 - 41.61
Market Cap	$2.04B
P/E Ratio	16.54
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	29.14%
Days to Cover	5.95

About Harmony Biosciences Holdings Inc

Sector

Health Care

Industry

Pharmaceuticals

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing ...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Harmony Biosciences (HRMY) stock?

You can purchase shares of Harmony Biosciences (NASDAQ:HRMY) through any online brokerage.

View our list of the best stock brokerages

Who are Harmony Biosciences (HRMY) competitors?

Other companies in Harmony Biosciences’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), WAVE Life Sciences (NASDAQ:WVE), Tarsus Pharmaceuticals (NASDAQ:TARS) and ANI Pharmaceuticals (NASDAQ:ANIP).

What is the forecast, or price target, for Harmony Biosciences (HRMY) stock?

Harmony Biosciences has a consensus price target of $50.21.

What is the current price for Harmony Biosciences (HRMY)?

The stock price for Harmony Biosciences (NASDAQ: HRMY) is $35.84 last updated February 20, 2025 at 6:56 PM EST.

Does Harmony Biosciences (HRMY) pay a dividend?

There are no upcoming dividends for Harmony Biosciences.

When is Harmony Biosciences (NASDAQ:HRMY) reporting earnings?

Harmony Biosciences’s Q1 earnings are confirmed for Tuesday, April 29, 2025.

Is Harmony Biosciences (HRMY) going to split?

There is no upcoming split for Harmony Biosciences.

What sector and industry does Harmony Biosciences (HRMY) operate in?

Harmony Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.